FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20351211000001103: Edarbi 40mg tablets (Takeda UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68829501000001112 Edarbi 40mg tablets (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68829601000001111 Edarbi 40mg tablets (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Edarbi 40mg tablets (Takeda UK Ltd) Is a Azilsartan medoxomil 40mg tablets true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has specific active ingredient Azilsartan medoxomil true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has specific active ingredient Azilsartan medoxomil potassium true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Azilsartan medoxomil true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Is a Product containing precisely azilsartan medoxomil 40 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has active ingredient Azilsartan medoxomil false Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Is a Edarbi true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has specific active ingredient Azilsartan medoxomil false Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Edarbi 40mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Edarbi 40mg tablets (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start